Table 2.
Comparison of the clinical indicators of the normal and abnormal myocardial marker group.
| Clinical indicators | Normal group | Abnormal group | χ2/t | P |
|---|---|---|---|---|
| (n = 131) | (n = 161) | |||
| Age (m) | 40.665 ± 41.506 | 34.713 ± 43.443 | 1.188 | 0.236 |
| Gender: male, n (%) | 87 (66.412) | 89 (55.280) | 3.288 | 0.070 |
| Female, n (%) | 44 (33.588) | 72 (44.720) | ||
| Hypotension, n (%) | 20 (15.267) | 50 (31.056)* | 9.879 | 0.002 |
| Shock, n (%) | 17 (12.977) | 49 (30.435)* | 12.58 | <0.001 |
| Vasoactive drugs, n (%) | 26 (19.847) | 64 (39.752)* | 13.42 | <0.001 |
| Heart failure, n (%) | 11 (8.397) | 35 (21.739)* | 9.688 | 0.002 |
| Respiratory failure, n (%) | 77 (58.779) | 119 (73.913)* | 7.497 | 0.006 |
| MODS, n (%) | 54 (41.221) | 108 (67.081)* | 19.55 | <0.001 |
| Death, n (%) | 10 (7.634) | 36 (22.360)* | 33.79 | <0.001 |
| PCIS | 80.081 ± 8.915 | 75.899 ± 8.540 | 4.074 | <0.001 |
*
Compared with the normal group, P < 0.01